![](https://investorshub.advfn.com/uicon/759024.png?cb=1613316366)
Wednesday, October 21, 2020 11:28:23 AM
Item 8.01. Other Events.
On October 20, 2020, Astrotech Corporation (the “Company”) issued a press release announcing that its subsidiary BreathTech Corporation signed a joint development and option agreement (the “Agreement”) with the Cleveland Clinic Foundation (the “Cleveland Clinic”). Pursuant to the Agreement, the Company and the Cleveland Clinic will collaborate in efforts to develop a rapid breath test for coronavirus infection or related indicators, using the Company’s mass spectrometry technology and collection of data related thereto through an investigator initiated clinical study performed by the Cleveland Clinic.
As previously reported, on April 14, 2020, the Company entered into a $541,500 Paycheck Protection Program Promissory Note and Agreement (the “PPP Promissory Note”) with a commercial bank (the “Bank”) under the Coronavirus Aid, Relief, and Economic Security Act. On October 19, 2020, the Company and the Bank entered into a Cash Reserve Agreement wherein the Company agreed to deliver to the Bank an amount equal to $541,500 (the “Cash Amount”), to be held in in a separate account in accordance with the terms and conditions of the Cash Reserve Agreement for the purpose of establishing a source of payment for the Company’s obligations to repay and/or obtain forgiveness of the PPP Promissory Note.
On October 20, 2020, the Company received a letter from the staff of the Fort Worth Regional Office of the U.S. Securities and Exchange Commission (the “SEC”) informing the Company that the SEC staff had concluded the previously announced informal, fact-finding inquiry relating to certain press releases issued by the Company in March 2020 regarding the BreathTest-1000™ lung disease screening device currently under development by the Company. The letter advised the Company that the SEC staff does not intend to recommend an enforcement action against the Company.
A copy of the Agreement, the press release and the Cash Reserve Agreement are attached hereto as Exhibits 99.1, 99.2 and 99.3, respectively.
https://ih.advfn.com/stock-market/NASDAQ/astrotech-ASTC/stock-news/83498903/current-report-filing-8-k
Recent ASTC News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 06:19:59 PM
- TSA Grants 1st Detect’s TRACER 1000 Acceptance onto the “Approved” Section of the Air Cargo Security Technology List • GlobeNewswire Inc. • 06/20/2024 01:00:00 PM
- ASTROTECH SUBSIDIARY AGLAB, INC. ANNOUNCES JOINT EFFORT WITH SC LABS • GlobeNewswire Inc. • 06/13/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 01:16:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 01:46:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 04:54:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:45:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:52:32 PM
- Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results • GlobeNewswire Inc. • 05/13/2024 08:45:44 PM
- Astrotech Announces Listing to the GSA as an Approved United States Government Vendor • GlobeNewswire Inc. • 04/08/2024 01:00:00 PM
- Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference • GlobeNewswire Inc. • 04/02/2024 01:00:00 PM
- Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000 • GlobeNewswire Inc. • 03/25/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:37:04 PM
- Astrotech Reports Second Quarter Of Fiscal Year 2024 Financial Results • GlobeNewswire Inc. • 02/12/2024 09:35:27 PM
- IBN Coverage Initiated for Astrotech Corp. • GlobeNewswire Inc. • 01/17/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:28:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 10:29:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2023 04:13:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:57:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 10:54:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 10:35:31 PM
- Astrotech Presents the First Process Control System for Cannabinoid Oil Distillation Systems • GlobeNewswire Inc. • 11/28/2023 02:04:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 06:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 08:58:39 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM